Table 3.
Study and prediction model | Cutoff score | % Specificity | % Sensitivity | PV+ | PV− | AUC | AUC 95% CI | P value |
---|---|---|---|---|---|---|---|---|
PTSD screens only | ||||||||
WTCD (N=2368) | ||||||||
SSSP | – | 88.8 | 92.5 | 39.4 | 99.3 | 0.907 | 0.883–0.930 | – |
PCPS | – | 82.2 | 93.7 | 29.3 | 99.4 | 0.880 | 0.856–0.903 | – |
Pain study (N=705) | ||||||||
SSSP | – | 95.6 | 94.3 | 70.1 | 99.4 | 0.949 | 0.917–0.982 | – |
PCPS | – | 95.6 | 94.3 | 70.1 | 99.4 | 0.949 | 0.917–0.982 | – |
Trauma study (N=225) | ||||||||
SSSP | – | 85.9 | 65.4 | 38.3 | 94.9 | 0.757 | 0.645–0.869 | – |
PCPS | – | 80.9 | 96.2 | 40.3 | 99.4 | 0.885 | 0.829–0.942 | – |
PTSD screens+risk factors | ||||||||
WTCD (N=2368) | ||||||||
SSSP+risk factors | 124 | 89.4 | 92.5 | 40.7 | 99.4 | 0.945 | 0.930–0.959 | <.0001 |
PCPS+risk factors | 158 | 85.7 | 93.1 | 33.9 | 99.4 | 0.943 | 0.932–0.956 | <.0001 |
Pain study (N=705) | ||||||||
SSSP+risk factors | 124 | 95.6 | 92.9 | 69.8 | 99.2 | 0.965 | 0.944–0.985 | .0725 |
PCPS+risk factors | 158 | 95.6 | 92.9 | 69.8 | 99.2 | 0.970 | 0.956–0.985 | .0516 |
Trauma study (N=225) | ||||||||
SSSP+risk factors | 124 | 87.4 | 65.4 | 40.1 | 95.0 | 0.874 | 0.813–0.935 | <.0001 |
PCPS+risk factors | 158 | 86.9 | 92.3 | 48.6 | 98.8 | 0.929 | 0.892–0.965 | .0063 |
PTSD screens+risk factors+demos | ||||||||
WTCD (N=2368) | ||||||||
SSSP+risk factors+demos | 178 | 91.2 | 90.2 | 42.7 | 99.2 | 0.949 | 0.937–0.961 | .0862 |
PCPS+risk factors+demos | 194 | 88.1 | 91.9 | 38.0 | 99.2 | 0.945 | 0.934–0.955 | .2497 |
Pain study (N=705) | ||||||||
SSSP+risk factors+demos | 178 | 95.9 | 88.6 | 70.4 | 98.7 | 0.966 | 0.947–0.984 | .7779 |
PCPS+risk factors+demos | 194 | 95.9 | 87.1 | 70.1 | 98.6 | 0.972 | 0.958–0.985 | .3673 |
Trauma study (N=225) | ||||||||
SSSP+risk factors+demos | 178 | 90.5 | 61.5 | 46.3 | 94.6 | 0.883 | 0.829–0.938 | .2337 |
PCPS+risk factors+demos | 194 | 88.4 | 80.8 | 48.3 | 97.2 | 0.928 | 0.892–0.965 | .8929 |
Demos=demographics.